Recently, the government relaxed foreign direct investment (FDI) norms for the space sector by allowing 100 per cent FDI in manufacture of components, systems or sub-systems for satellites, ground segments, and user segments. It also permitted 74 per cent FDI in satellite manufacturing and operation as well as satellite data products and 49 per cent in development of launch vehicles and spaceports. Following this, stocks of related companies saw an uptick on the bourses.
Global pharma firm AstraZeneca on Tuesday said it had filed a lawsuit in the United States District Court of New Jersey
Under the agreement, MedImmune has granted Sun Pharma a licence to certain patents, permitting Sun Pharma to continue marketing its generic version of Ethyol in the US.
Close on the heels of introducing drugs for treatment of cancer and cardiovascular diseases, Anglo-Swedish pharmaceutical major AstraZeneca on Tuesday said it would launch one more medicine this year and two next year in India.
HAL has integrated the ASRAAM (advanced short range air-to-air missile) for the Tejas Mark 1A. The Tejas Mark 1A will carry twin ASRAAM missiles with a range of 60 to 70 kilometres.
Hindustan Aeronautics (HAL) is one of the largest beneficiaries of the defence indigenisation programme. The aerospace Public Sector Undertaking (PSU) has just received a new tender for 97 Light Combat Aircraft (LCA) Tejas Mk1A, and it is already servicing an earlier order for 83 LCA aircraft. The new order is worth around Rs 65,000 crore with a 65 per cent indigenisation component, whereas the earlier order (February 21) was worth Rs 45,700 crore with 55 per cent indigenisation.
The anti-aircraft missile, capable of ducking radar eyes and attacking enemy targets up to 110 km, was test fired from launch pad number 2 of the ITR complex at about 11.47 am, defence sources said. The test was conducted after an analysis of the data generated from yesterday's flight trial in order to further validate all major parameters, they said.
Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at long-term safety of the BBV152 vaccine in adolescents and adults, claimed.
Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".
The aircraft deal worth around Euro 5.5 billion was cleared by the defence acquisition council just before the visit of the Indian Prime Minister to France as the state guest for their Bastille Day parade this year in July.
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.
Ananya introduces you to her #DostAstra... Hina's world is upside down... Mrunal glows in yellow...
The mesmerizing march included elite marching contingents, missiles, warplanes, surveillance gadgets and lethal weapon systems, with French President Emmanuel Macron gracing the occasion as the chief guest.
Following up first doses of the AstraZeneca or Pfizer vaccines with second doses of the Moderna or Novavax jabs generates robust immune response against COVID-19, according to a study published in The Lancet journal.
The extended range Astra Mark 2 would give India an edge over its adversaries and would add more lethality to its fighter jets in aerial combat, like the one which happened a day after the Balakot airstrikes on February 26, 2019.
SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million doses a month from 100 million a month now, reports Sohini Das.
Director Ayan Mukerji has started introducing the main characters of his mega movie Brahmastra, Part One: Shiva.
As the festival of colours draws near, here's a row of fashionable looks inspired by the hues of Holi.
'Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine for both doses,' Nordstrom said.
"I've just received my first Oxford/AstraZeneca vaccine dose. Thank you to all of the incredible scientists, NHS staff and volunteers who helped make this happen," he tweeted. "Getting the jab is the best thing we can do to get back to the lives we miss so much. Let's get the jab done," he added in his tweet.
If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.
The researchers from King's College London in the United Kingdom also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days.
There is confusion over the United Kingdom government's vaccine recognition process for Indian travellers as even though Oxford/AstraZeneca Covishield, the India-manufactured Oxford/AstraZeneca COVID-19 vaccine, is on an updated international travel advisory, India is not yet on a list of 17 approved countries.
AstraZeneca Plc and the University of Oxford are facing questions about their Covid-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to the New York Times.
The real value of the Tejas Mark 1 is the role it will now play in the development of India's next generation of fighter aircraft that will be more technologically advanced and lethal.
According to the study, 'mixed' schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart.
Notwithstanding the risk involved, analysts are upbeat on micro-cap investing as India remains in a firm bull market. Moreover, these stocks are available at relatively cheaper valuations compared to large, mid and small caps, assuring alpha returns. With a market-capitalisation (market-cap) of up to Rs 10,000 crore, micro-cap stocks are outside the purview of Nifty 500 stocks, and are ranked from 501 to 750 in the market-cap ladder.
Birthday wishes have been pouring in for Ranbir Kapoor as he turns 40 on September 28.
"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.
Earlier this week, AstraZeneca said it had paused the trials because of 'an unexplained illness' in a participant in the study.
Adar Poonawalla says it took a five-minute chat with his father Cyrus before making the decision to manufacture Covishield. The bet paid off, and handsomely. Serum Institute now has the capacity to make 4 billion doses of Covishield annually.
The comments came after AstraZeneca and Oxford University acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date.
'Once DCGI will give us the permission to restart the trials in India, we will resume the trials,' Serum Institute of India (SII) said in a statement.
The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.
Sukanya Verma lists her 15 favourite Hindi songs of 2022 in no particular order.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances